Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Some herbs show promise as antiandrogenic agents.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

RTA 408 cream protects mice from radiation skin damage.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Finasteride helps female-pattern hair loss.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Trazodone might help reverse post finasteride syndrome.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Kartogenin may help treat hair loss by promoting hair growth and extending the hair growth phase.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Dutasteride may reduce insulin sensitivity and increase body fat.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Finasteride may reduce prostate tumor cell invasion and spread.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.